Ferritin Lab Results: Normal Reference Range vs. Functional Optimal Range

At a glance
- Standard lab reference range / 12 to 300 ng/mL (varies by lab and sex)
- Functional optimal target (premenopausal women) / 50 to 150 ng/mL
- Functional optimal target (men and postmenopausal women) / 75 to 200 ng/mL
- WHO threshold for depleted iron stores / ferritin below 15 ng/mL
- Symptoms can begin at / ferritin below 30 to 50 ng/mL despite "normal" lab flags
- Ferritin above 500 ng/mL / warrants investigation for iron overload or inflammation
- Most common cause of low ferritin / inadequate dietary iron or chronic blood loss
- Best absorption pairing / oral iron plus vitamin C on an empty stomach
- Recheck interval after supplementation / 8 to 12 weeks minimum
What Ferritin Actually Measures
Ferritin is the primary storage protein for iron in the human body. Each ferritin molecule can hold up to 4,500 iron atoms within its hollow spherical shell. The small amount of ferritin that leaks into the bloodstream reflects total body iron reserves, making a serum ferritin test the single most useful first-line marker for iron status [1].
A ferritin result does not tell you how much iron is circulating in plasma right now. That job belongs to serum iron and transferrin saturation. Ferritin answers a different question: how deep are the reserves? Think of it as the balance in a savings account versus what is in your checking account. You can have adequate circulating iron while your reserves run dangerously low. This distinction matters because symptoms of iron depletion (fatigue, brain fog, hair shedding, exercise intolerance) often appear well before outright anemia develops on a complete blood count [2].
Ferritin is also an acute-phase reactant. Infection, chronic inflammation, liver disease, and malignancy can all push ferritin higher, independent of iron stores. A single elevated reading does not automatically mean iron overload. Context, including C-reactive protein and transferrin saturation, determines interpretation [3].
Why the Standard "Normal" Range Is Misleading
Most commercial laboratories report a ferritin reference interval somewhere between 12 and 300 ng/mL for adult women and 12 to 300 ng/mL (sometimes up to 400 ng/mL) for adult men. These ranges are derived statistically from the central 95% of a reference population. They define what is common. They do not define what is ideal.
A premenopausal woman with a ferritin of 14 ng/mL may receive a result flagged "normal" or "low normal." She is technically within range. She may also be losing hair, sleeping poorly, and struggling through workouts. The World Health Organization defines depleted iron stores as ferritin below 15 ng/mL [4], yet many lab printouts would not flag that value as abnormal.
On the other end, a man with ferritin at 290 ng/mL sits inside the standard range. But if his transferrin saturation exceeds 45%, hereditary hemochromatosis screening with HFE gene testing is recommended by the American Association for the Study of Liver Diseases, regardless of where ferritin falls relative to the lab range [5]. The standard reference interval gives a false sense of security on both tails.
The core problem is that lab reference ranges describe population distribution, not clinical optimization. A ferritin of 20 ng/mL is "normal" only in the sense that a large number of menstruating women share that value. It is not optimal.
Functional Optimal Ferritin Targets by Population
Functional ranges aim to identify the zone where iron-dependent processes (oxygen transport, mitochondrial energy production, thyroid hormone synthesis, collagen formation, neurotransmitter metabolism) operate without bottleneck. No single randomized trial has defined a universal "optimal" ferritin, but convergent evidence from multiple clinical contexts supports tighter targets.
Premenopausal women: A ferritin target of 50 to 150 ng/mL aligns with data showing that symptoms of iron deficiency, including fatigue and hair loss, improve most reliably once ferritin exceeds 50 ng/mL. A 2017 systematic review in the American Journal of Medicine found that intravenous iron improved fatigue scores in non-anemic women whose baseline ferritin was below 50 ng/mL [6]. The Endocrine Society's clinical practice guidelines on premenopausal bone health also note that iron adequacy supports hormone metabolism [7].
Men and postmenopausal women: A range of 75 to 200 ng/mL balances adequate reserves against the cardiovascular and hepatic risks associated with higher iron burdens. Epidemiologic data from the NHANES cohort demonstrate that men with ferritin above 300 ng/mL carry increased risk of metabolic syndrome, independent of BMI [8].
Endurance athletes: Sports medicine literature suggests a ferritin floor of 35 to 50 ng/mL before performance decrements appear, with some authors arguing for a target above 50 ng/mL for competitive endurance athletes who experience exercise-induced hemolysis and foot-strike hemolysis [9].
Pregnancy: The WHO recommends ferritin above 30 ng/mL in early pregnancy to reduce risk of iron-deficiency anemia in the third trimester [4]. Many maternal-fetal medicine specialists target 50 to 70 ng/mL by the second trimester.
Heart failure patients: The 2021 ESC heart failure guidelines define iron deficiency as ferritin below 100 ng/mL (or 100 to 299 ng/mL with transferrin saturation below 20%) and recommend intravenous iron replacement in symptomatic HFrEF patients meeting those criteria, based on the AFFIRM-AHF trial [10].
These functional targets are not arbitrary. They reflect thresholds where clinical intervention has demonstrated measurable benefit.
How to Interpret Your Ferritin Result in Context
A ferritin number alone is incomplete. Three additional data points sharpen interpretation.
Transferrin saturation (TSAT). Calculated from serum iron divided by total iron-binding capacity. A ferritin of 250 ng/mL with TSAT at 22% likely reflects inflammatory elevation, not iron overload. That same ferritin with TSAT above 45% raises genuine concern for hemochromatosis [5].
C-reactive protein (CRP). Because ferritin rises with inflammation, a concurrent CRP helps you determine whether an elevated ferritin is an iron story or an inflammation story. The WHO recommends adjusting ferritin interpretation whenever CRP exceeds 5 mg/L [4].
Complete blood count (CBC). Microcytic anemia (low MCV, low hemoglobin) combined with low ferritin confirms iron-deficiency anemia. But ferritin can be low for months before MCV drops. Waiting for microcytosis before treating means waiting too long.
A practical decision rule: if ferritin is below 30 ng/mL in any adult, iron repletion is reasonable regardless of hemoglobin. If ferritin is between 30 and 50 ng/mL and symptoms consistent with iron deficiency are present, a therapeutic trial of iron supplementation for 8 to 12 weeks with ferritin recheck is clinically defensible.
What Causes Low Ferritin
The most common cause globally is inadequate dietary iron relative to demand. Menstruating women lose approximately 1 mg of iron per day through blood loss alone, on top of the 1 mg lost through skin, gut, and urinary shedding. Total daily iron need for premenopausal women is roughly 18 mg of dietary iron to absorb that 2 mg, because non-heme iron absorption efficiency sits between 5 to 12% [11].
Other contributors to low ferritin:
Gastrointestinal blood loss. Occult GI bleeding from NSAID gastropathy, celiac disease, inflammatory bowel disease, or colorectal lesions is the leading non-menstrual cause of iron depletion in adults. Any male or postmenopausal female with unexplained iron deficiency warrants GI evaluation [12].
Malabsorption. Celiac disease, autoimmune gastritis, H. pylori infection, and prior bariatric surgery all impair iron absorption. In celiac disease, iron deficiency may be the sole presenting sign in up to 40% of cases [13].
High-demand states. Pregnancy, lactation, rapid growth in adolescence, and intensive endurance training all increase iron requirements beyond what a standard diet provides.
Dietary restriction. Vegetarian and vegan diets contain only non-heme iron, which has lower bioavailability than heme iron found in animal tissue. Supplementation or deliberate pairing with vitamin C and avoidance of concurrent calcium, tea, and coffee at iron-containing meals becomes important [11].
Frequent blood donation. A single whole-blood donation removes roughly 200 to 250 mg of iron. Donors who give three or more times per year without supplementation commonly develop depleted stores [14].
How to Raise Ferritin
Oral iron supplementation remains first-line therapy for most patients with low ferritin. Ferrous sulfate 325 mg (65 mg elemental iron) taken every other day on an empty stomach with vitamin C produces absorption equivalent to or better than daily dosing, with fewer GI side effects. A 2017 randomized crossover trial in Blood showed that alternate-day dosing increased fractional iron absorption by 34% compared with consecutive-day dosing, because hepcidin (the master iron-regulatory hormone) spikes for 24 hours after an oral iron dose and suppresses absorption of the next dose [15].
Practical protocol for oral repletion:
- Take 65 mg elemental iron every other morning, 30 minutes before food.
- Co-administer 200 mg vitamin C (ascorbic acid) to convert ferric iron to the more absorbable ferrous form.
- Avoid calcium supplements, dairy, coffee, and tea within 2 hours of the iron dose.
- Recheck ferritin at 8 to 12 weeks. Expect a rise of roughly 1 to 2 ng/mL per day of therapy in the absence of ongoing losses.
- Continue supplementation until ferritin reaches the target range (50+ ng/mL for most patients), then transition to a maintenance dose or dietary strategy.
When to consider IV iron. Intravenous iron (ferric carboxymaltose or iron sucrose) is appropriate when oral iron is not tolerated, absorption is impaired, the deficit is severe (ferritin below 15 ng/mL with anemia), or rapid repletion is needed (second/third trimester pregnancy, preoperative optimization, symptomatic heart failure). A single infusion of ferric carboxymaltose 750 mg can raise ferritin by 200 to 300 ng/mL within 2 to 4 weeks [16].
Dietary strategies alone rarely correct a true deficit within a clinically useful timeframe. Red meat, organ meats, oysters, and dark poultry meat provide the best-absorbed heme iron. Spinach and lentils contribute non-heme iron that can supplement but not replace targeted repletion when stores are depleted.
What Causes High Ferritin and How to Lower It
Ferritin above 300 ng/mL in men or above 200 ng/mL in premenopausal women warrants clinical attention. The differential diagnosis splits into two broad categories.
Iron overload (elevated ferritin with elevated TSAT). Hereditary hemochromatosis (HFE C282Y homozygosity) affects roughly 1 in 200 people of Northern European descent [5]. Repeated transfusions in chronic anemias (thalassemia, myelodysplastic syndromes) also produce true iron overload. Treatment is phlebotomy: removal of 500 mL of whole blood (containing approximately 250 mg iron) every 1 to 2 weeks until ferritin drops below 50 to 100 ng/mL, then maintenance phlebotomy every 2 to 4 months [17].
Inflammatory or metabolic elevation (elevated ferritin with normal or low TSAT). This pattern is far more common than hemochromatosis. Causes include metabolic-associated steatotic liver disease (MASLD), type 2 diabetes, obesity, alcohol use, chronic infection, autoimmune disease, and malignancy. In these cases, treating the underlying condition lowers ferritin. Weight loss of 7 to 10% body weight reduces ferritin by an average of 30 to 50% in patients with MASLD, according to data from the PIVENS trial [18].
Specific strategies to lower ferritin when iron overload is confirmed:
- Therapeutic phlebotomy (gold standard for hemochromatosis)
- Chelation therapy (deferasirox or deferoxamine) when phlebotomy is contraindicated due to anemia [17]
- Dietary limitation of heme iron and avoidance of vitamin C supplements with meals (vitamin C increases iron absorption)
- Avoidance of iron-fortified foods and supplements
- Limiting alcohol, which increases intestinal iron absorption and promotes hepatic iron loading
For inflammatory ferritin elevation without true iron overload, phlebotomy is generally not indicated. The target is the inflammation itself.
Ferritin, Hair Loss, and Restless Legs: Clinical Thresholds
Two conditions with strong ferritin associations deserve specific mention.
Telogen effluvium and chronic diffuse hair loss. A 2006 study in the Journal of the American Academy of Dermatology found that women with chronic telogen effluvium had significantly lower ferritin than age-matched controls (mean 28 ng/mL vs. 59 ng/mL) [19]. Many dermatologists now recommend maintaining ferritin above 70 ng/mL for women presenting with diffuse hair shedding, even when standard lab ranges would call 28 ng/mL "normal."
Dr. Leonid Benjamin Trost, writing in the same journal, noted: "Treatment of iron deficiency with resultant rise in serum ferritin can augment hair regrowth even in the absence of frank anemia" [19].
Restless legs syndrome (RLS). The International Restless Legs Syndrome Study Group recommends checking ferritin in all RLS patients and supplementing iron when ferritin falls below 75 ng/mL, a threshold well above most lab "normal" lower limits [20]. A 2019 Cochrane review confirmed that iron supplementation improved RLS symptom severity scores compared with placebo in patients with serum ferritin below 75 ng/mL [21].
These two examples illustrate why functional ranges exist. Waiting for ferritin to drop below 12 ng/mL before intervening misses months or years of reversible symptoms.
Retesting Frequency and Monitoring
After initiating iron repletion, recheck ferritin no sooner than 8 weeks. Ferritin reflects stored iron, and stores take time to rebuild. Checking at 4 weeks often shows discouraging numbers that lead to premature dose escalation.
For patients on maintenance after reaching target: recheck ferritin every 6 to 12 months. Premenopausal women with heavy menstrual bleeding may need checks every 6 months.
For patients with hemochromatosis on phlebotomy maintenance: the AASLD recommends monitoring ferritin every 2 to 3 months during initial depletion, then every 3 to 6 months during maintenance, targeting ferritin between 50 to 100 ng/mL [17].
One often-missed point: ferritin drawn during acute illness, surgery recovery, or active infection will read falsely high. Wait at least 4 to 6 weeks after resolution of any acute inflammatory event before using ferritin for iron-status decisions.
Frequently asked questions
›What is a normal ferritin level?
›What does a high ferritin level mean?
›What does a low ferritin level mean?
›What does ferritin mean in a blood test?
›Can ferritin be high even if you are not iron-overloaded?
›How long does it take to raise ferritin with supplements?
›What ferritin level causes hair loss?
›What ferritin level is needed for restless legs syndrome?
›Is ferritin affected by inflammation?
›How often should I recheck ferritin?
›Should I take iron every day or every other day?
›Can I get enough iron from food alone?
References
- Wang W, Knovich MA, Coffman LG, et al. Serum ferritin: past, present and future. Biochim Biophys Acta. 2010;1800(8):760-769. https://pubmed.ncbi.nlm.nih.gov/20304033
- Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372(19):1832-1843. https://pubmed.ncbi.nlm.nih.gov/25946282
- Kell DB, Pretorius E. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. Metallomics. 2014;6(4):748-773. https://pubmed.ncbi.nlm.nih.gov/24549403
- World Health Organization. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations. Geneva: WHO; 2020. https://www.who.int/publications/i/item/9789240000124
- Bacon BR, Adams PC, Kowdley KV, et al. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011;54(1):328-343. https://pubmed.ncbi.nlm.nih.gov/21452290
- Houston BL, Hurrie D, Graham J, et al. Efficacy of iron supplementation on fatigue and physical capacity in non-anaemic iron-deficient adults: a systematic review of randomised controlled trials. BMJ Open. 2018;8(4):e019240. https://pubmed.ncbi.nlm.nih.gov/29626044
- Endocrine Society. Management of osteoporosis in premenopausal women. J Clin Endocrinol Metab. 2020. https://academic.oup.com/jcem
- Jehn M, Clark JM, Guallar E. Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care. 2004;27(10):2422-2428. https://diabetesjournals.org/care/article/27/10/2422/22774
- Peeling P, Dawson B, Goodman C, et al. Athletic induced iron deficiency: new insights into the role of inflammation, cytokines and hormones. Eur J Appl Physiol. 2008;103(4):381-391. https://pubmed.ncbi.nlm.nih.gov/18365240
- Ponikowski P, Kirwan BA, Anker SD, et al. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial (AFFIRM-AHF). Lancet. 2020;396(10266):1895-1904. https://pubmed.ncbi.nlm.nih.gov/33197395
- Office of Dietary Supplements, National Institutes of Health. Iron: Fact Sheet for Health Professionals. Updated 2023. https://ods.od.nih.gov/factsheets/Iron-HealthProfessional
- Rockey DC, Cello JP. Evaluation of the gastrointestinal tract in patients with iron-deficiency anemia. N Engl J Med. 1993;329(23):1691-1695. https://pubmed.ncbi.nlm.nih.gov/8232457
- Fasano A, Catassi C. Celiac disease. N Engl J Med. 2012;367(25):2419-2426. https://pubmed.ncbi.nlm.nih.gov/23252527
- Cable RG, Glynn SA, Kiss JE, et al. Iron deficiency in blood donors: the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion. 2012;52(4):702-711. https://pubmed.ncbi.nlm.nih.gov/21995532
- Stoffel NU, Cercamondi CI, Brittenham G, et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split doses: a randomised crossover trial. Lancet Haematol. 2017;4(11):e524-e533. https://pubmed.ncbi.nlm.nih.gov/29032957
- Onken JE, Bregman DB, Engel RA, et al. Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. Nephrol Dial Transplant. 2014;29(4):833-842. https://pubmed.ncbi.nlm.nih.gov/24084325
- European Association for the Study of the Liver. EASL clinical practice guidelines for HFE hemochromatosis. J Hepatol. 2010;53(1):3-22. https://pubmed.ncbi.nlm.nih.gov/20471131
- Sanyal AJ, Chalasani N, Kowdley KV, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis (PIVENS). N Engl J Med. 2010;362(18):1675-1685. https://pubmed.ncbi.nlm.nih.gov/20427778
- Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol. 2006;54(5):824-844. https://pubmed.ncbi.nlm.nih.gov/16635664
- Allen RP, Picchietti DL, Auerbach M, et al. Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report. Sleep Med. 2018;41:27-44. https://pubmed.ncbi.nlm.nih.gov/29425576
- Trotti LM, Becker LA. Iron for the treatment of restless legs syndrome. Cochrane Database Syst Rev. 2019;1:CD007834. https://pubmed.ncbi.nlm.nih.gov/30609006